Valeo Financial Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,371
Closed -$11K 658
2023
Q1
$11K Hold
10,371
﹤0.01% 607
2022
Q4
$15.8K Buy
+10,371
New +$17.8K ﹤0.01% 530
2021
Q4
Sell
-10,319
Closed -$51K 625
2021
Q3
$51K Buy
+10,319
New +$59.4K ﹤0.01% 554
2021
Q2
Sell
-8,069
Closed -$56K 1438
2021
Q1
$56K Buy
8,069
+350
+5% +$2.96K ﹤0.01% 827
2020
Q4
$79K Buy
7,719
+1,050
+16% +$6.81K ﹤0.01% 637
2020
Q3
$23K Buy
6,669
+150
+2% +$712 ﹤0.01% 888
2020
Q2
$33K Buy
6,519
+3,500
+116% +$11.9K ﹤0.01% 883
2020
Q1
$9K Sell
3,019
-7,550
-71% -$32.6K ﹤0.01% 1134
2019
Q4
$58K Sell
10,569
-500
-5% -$2.81K 0.01% 594
2019
Q3
$63K Hold
11,069
0.01% 534
2019
Q2
$85K Buy
11,069
+500
+5% +$2.69K 0.01% 466
2019
Q1
$56K Buy
10,569
+4,000
+61% +$27.7K 0.01% 529
2018
Q4
$43K Buy
6,569
+500
+8% +$5.6K 0.01% 534
2018
Q3
$70K Buy
6,069
+1,000
+20% +$14.9K 0.01% 480
2018
Q2
$71K Hold
5,069
0.01% 468
2018
Q1
$78K Buy
5,069
+2,000
+65% +$28.6K 0.01% 406
2017
Q4
$35K Buy
+3,069
New +$45.7K 0.01% 545

Other funds holding PGEN

Valeo Financial Advisors's PGEN Position: Q2 2023 in Review

Valeo Financial Advisors sold out of Precigen (PGEN) in Q2 2023, closing a stake of 10,371 shares — an estimated $11K sold.

Valeo Financial Advisors first reported a position in PGEN in Q4 2017 and held it in 17 quarters. The position peaked at $85K in Q2 2019. 138 funds tracked by Wall St. Rank hold PGEN as of Q2 2023.

  • Valeo Financial Advisors reported no remaining Precigen position as of Q2 2023 after selling out during the quarter.
  • Valeo Financial Advisors sold 10,371 Precigen shares in Q2 2023, an estimated $11K.
  • Valeo Financial Advisors first reported a position in Precigen in Q4 2017 and held it in 17 quarters.
  • Valeo Financial Advisors's Precigen position peaked at $85K in Q2 2019.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q2 2023.

Based on Valeo Financial Advisors's 13F filing for Q2 2023, filed 14 Jul 2023.